# OnCo record dnx-2401 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/dnx-2401/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "dnx-2401" ;
  schema:name "DNX-2401"@en ;
  schema:alternateName "DNX2401"@en, "Delta-24-RGD-4C"@en, "Ad5-DNX-2401"@en ;
  schema:description "DNX-2401 is an experimental oncolytic adenovirus from DNAtrix, in phase 2 trials for recurrent glioblastoma, malignant glioma and diffuse intrinsic pontine glioma and other cancers; its current status is not stated."@en ;
  schema:url <https://onco.cc/drugs/dnx-2401/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.biospace.com/dnatrix-announces-first-patient-dosed-in-clinical-study-of-dnx-2440-an-ox40-ligand-expressing-immunotherapy-in-colorectal-cancer-and-other-cancers-with-liver-metastasis>, <https://www.biospace.com/dnatrix-announces-first-patient-dosed-in-clinical-study-of-dnx-2440-an-ox40-ligand-expressing-immunotherapy-in-colorectal-cancer-and-other-cancers-with-liver-metastasis>, <https://clinicaltrials.gov/study/NCT00805376>, <https://clinicaltrials.gov/search?intr=DNX-2401> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Oncolytic adenovirus" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/>, <https://onco.cc/cancers/metastatic-cancer/>, <https://onco.cc/cancers/dipg-dmg/>, <https://onco.cc/cancers/brain-tumours/>, <https://onco.cc/cancers/melanoma/> ;
  onco:companies <https://onco.cc/companies/dnatrix/> ;
  onco:trials <https://onco.cc/trials/nct00805376/>, <https://onco.cc/trials/nct02197169/>, <https://onco.cc/trials/nct02798406/>, <https://onco.cc/trials/nct01956734/>, <https://onco.cc/trials/nct03178032/>, <https://onco.cc/trials/nct03896568/>, <https://onco.cc/trials/nct05009992/>, <https://onco.cc/trials/nct07424092/>, <https://onco.cc/trials/nct07444606/> .